Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.

MLA

Brooks, Tracy A., et al. “Taxane-Based Reversal Agents Modulate Drug Resistance Mediated by P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein.” Molecular Cancer Therapeutics, vol. 2, no. 11, Nov. 2003, pp. 1195–205. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14617793&authtype=sso&custid=ns315887.

APA

Brooks, T. A., Minderman, H., O’Loughlin, K. L., Pera, P., Ojima, I., Baer, M. R., & Bernacki, R. J. (2003). Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Molecular Cancer Therapeutics, 2(11), 1195–1205.

Chicago

Brooks, Tracy A, Hans Minderman, Kieran L O’Loughlin, Paula Pera, Iwao Ojima, Maria R Baer, and Ralph J Bernacki. 2003. “Taxane-Based Reversal Agents Modulate Drug Resistance Mediated by P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein.” Molecular Cancer Therapeutics 2 (11): 1195–1205. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14617793&authtype=sso&custid=ns315887.